Evidence map›Paper›PMID 42444948›Full record

ArticleJournal of thoracic disease2026

Global trends and inequalities in environmental risk-attributable chronic obstructive pulmonary disease mortality among adults aged 80+ years, 1990-2021: an analysis of the Global Burden of Disease Study 2021.

Yan Wang, Shuai Jiang, Chengzeng Wang

Abstract read
In one paragraph

Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yan WangDepartment of Social Medicine and Health Management, College of Public Health, Zhengzhou University, Zhengzhou, China.ORCID https://orcid.org/0009-0006-9832-8478
Shuai JiangDepartment of Social Medicine and Health Management, College of Public Health, Zhengzhou University, Zhengzhou, China.
Chengzeng WangDepartment of Social Medicine and Health Management, College of Public Health, Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: While the aging global population faces a rising chronic obstructive pulmonary disease (COPD) mortality burden, comprehensive assessments of this burden concerning multiple environmental risks and socioeconomic inequalities among the oldest-old (aged ≥80 years) remain limited. This study aims to comprehensively assess the burden of environmental risk-attributable COPD mortality, its temporal trends, and socioeconomic inequalities among the global population aged ≥80 years. Methods: Data from the Global Burden of Disease (GBD) Study 2021 were used to analyse COPD deaths and age-specific mortality rates attributable to eight environmental risk factors among adults aged 80 years and older from 1990 to 2021. Mortality estimates were derived from multiple GBD data sources, including household surveys, censuses, and vital registration systems. We examined mortality patterns and trends at the global, regional, and national levels. Temporal trends in age-specific mortality rates were assessed using Joinpoint regression, and Socio-demographic Index (SDI) related inequalities across 204 countries were evaluated using the slope index of inequality (SII) and relative concentration index (RCI). Results: In 2021, the leading environmental risk factors for age-specific COPD mortality rates were smoking {351.85 per 100,000 population [95% uncertainty interval (UI): 268.79-433.10]}, ambient particulate matter pollution [241.60 (175.22-299.69) per 100,000 population], and household air pollution from solid fuels (HAP) [157.27 (83.42-292.74) per 100,000 population]. The leading contributor to male COPD mortality was smoking [717.70 (555.94-871.14) per 100,000] and ambient particulate matter pollution [335.99 (245.85-411.01) per 100,000 population], whereas female mortality was primarily driven by ambient particulate matter pollution [181.00 (123.04-234.92) per 100,000 population] and HAP [141.30 (76.19-250.28) per 100,000 population]. From 1990 to 2021, COPD mortality rates attributable to HAP showed the largest reduction [percentage change: -72% (-83% to -53%)]. Joinpoint regression revealed temporal patterns. Smoking attributable mortality increased until 1998, then sustained a decline. Ambient particulate matter pollution attributable mortality rose until 2014 before decreasing. Ambient ozone attributable mortality followed a fluctuating pattern. High temperature was the only factor among the eight assessed with a statistically significant, overall increasing trend throughout 1990-2021 {annual percent change: 1.49% [95% confidence interval (CI): 0.98-2.00]}. In terms of health inequalities, HAP demonstrated the highest degree of socio-demographic inequality in 2021 [RCI: -0.404 (-0.474 to -0.334); SII: -545.59 (-637.30 to -453.89) per 100,000 population], with the relative inequality increasingly concentrated in lower-SDI countries. For ambient particulate matter pollution, absolute inequality shifted increasingly toward disadvantaged settings. Notably, both absolute and relative inequalities in ozone-attributable COPD mortality increased from 1990 to 2021, with mortality disproportionately concentrated in lower-SDI countries. Conclusions: These findings provide a critical evidence base for formulating integrated public health strategies aimed at mitigating burdens of environmental risk-attributable COPD mortality among adults aged 80 years and older. Such strategies entail prioritizing clean energy, clean cooking technologies, and ozone control in lower-SDI regions, along with reinforcing tobacco and climate-related actions globally.

Indexed as

Chronic obstructive pulmonary disease (COPD)environmental risk factorsGlobal Burden of Disease (GBD)health inequalitieshealthy aging

Identifiers

PMID42444948
PMCPMC13358501

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.